


Eliglustat Chemical - Cas No: 491833-29-5
Price:
Get Latest Price
Minimum Order Quantity :
1
In Stock
Product Specifications
| Molecular Formula | C23H36N2O4 |
| Molecular Weight | 404.54294 Drams (dr) |
| Place of Origin | China |
| Other Names | Eliglustat;Genz 99067;N-[(1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-octanamide;N-[(1R,2R)-1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(1- pyrrolidinyl)-2-propanyl]octanamide;Eliglustat(Genz-99067) |
| CAS No | 491833-29-5 |
| Usage | Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease. Patients selected for treatment with Eliglustat undergo an FDA approved genotype |
| Purity | 99% |
| Smell | Other |
| Color | Other |
| Form | Powder |
| FOB Port | Shanghai |
| Payment Terms | Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Others, Cash Advance (CA) |
| Supply Ability | 1000 Per Week |
| Delivery Time | 15 Days |
| Sample Available | Yes |
| Sample Policy | Contact us for information regarding our sample policy |
| Packaging Details | foil bag/ plastic bag/bottles |
| Main Export Market(s) | Australia, North America, Eastern Europe, Middle East, Africa, Western Europe, Central America, South America, Asia |
Company Details
Focusing on a customer-centric approach, CHEMVON BIOTECHNOLOGY (SHANGHAI) CO. LTD. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pharmaceutical Chemicals in bulk from CHEMVON BIOTECHNOLOGY (SHANGHAI) CO. LTD. at Trade India quality-assured products.
Business Type
Exporter, Manufacturer, Distributor, Supplier, Trading Company
Employee Count
250
Establishment
2004
Working Days
To
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
Shanghai, Shanghai
CEO
Mr. Peter Dong Wang
Members since
14 Years
Address
Suite B-10, Chuansha Road 6999#, Shanghai, Shanghai, 201203, China
active pharmaceutical ingredients in Shanghai
Report incorrect details

































